174 related articles for article (PubMed ID: 20462450)
1. Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.
Mangone FR; Walder F; Maistro S; Pasini FS; Lehn CN; Carvalho MB; Brentani MM; Snitcovsky I; Federico MH
Mol Cancer; 2010 May; 9():106. PubMed ID: 20462450
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
6. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.
Sabbineni H; Verma A; Somanath PR
J Cell Physiol; 2018 Nov; 233(11):8418-8428. PubMed ID: 29856065
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
9. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
[TBL] [Abstract][Full Text] [Related]
10. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
11. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway.
Peng H; Shintani S; Kim Y; Wong DT
Neoplasia; 2006 Dec; 8(12):1028-36. PubMed ID: 17217620
[TBL] [Abstract][Full Text] [Related]
12. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
[TBL] [Abstract][Full Text] [Related]
14. Mechanical stretch down-regulates expression of the Smad6 gene in cultured rat mesangial cells.
Hayashi Y; Katoh T; Asano K; Onozaki A; Sakurai K; Asahi K; Nakayama M; Watanabe T
Clin Exp Nephrol; 2012 Oct; 16(5):690-6. PubMed ID: 22581061
[TBL] [Abstract][Full Text] [Related]
15. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma.
Ong HS; Gokavarapu S; Tian Z; Li J; Xu Q; Zhang CP; Cao W
J Oral Pathol Med; 2018 Aug; 47(7):652-659. PubMed ID: 29660835
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
17. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
18. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.
Lee YS; Kim JH; Kim ST; Kwon JY; Hong S; Kim SJ; Park SH
Biochem Biophys Res Commun; 2010 Mar; 393(4):836-43. PubMed ID: 20171181
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta isoforms (TGF-beta1, TGF-beta2, TGF-beta3) messenger RNA expression in laryngeal cancer.
Kapral M; Strzalka B; Kowalczyk M; Jurzak M; Mazurek U; Gierek T; Paluch J; Markowski J; Swiatkowska L; Weglarz L
Am J Otolaryngol; 2008; 29(4):233-7. PubMed ID: 18598833
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
